VMP 10161711000001105

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Levodopa 20mg/ml / Carbidopa monohydrate 5mg/ml intestinal gel 100ml cassette
BNF code 0409010N0AAARAR
Virtual Therapeutic Moiety Co-careldopa
Abbreviated name Levodopa 20mg/ml/Carbidopa monohydrate 5mg/ml intestinal gel
Basis of preferred name Other
Date of name applicability 11 Dec 2024
Previous name Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette
Basis of previous name BAN - British Approved Name
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units cassette
Unit dose unit of measure cassette
Virtual Product Ingredient
Ingredient Levodopa
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 20.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Virtual Product Ingredient
Ingredient Carbidopa monohydrate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 5.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route intestinalgel.intestinal
Dose Form
Formulation Intestinal gel
Drug Route
Route Intestinal
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Duodopa intestinal gel 100ml cassette (AbbVie Ltd)
Virtual Medicinal Product Packs
Levodopa 20mg/ml / Carbidopa monohydrate 5mg/ml intestinal gel 100ml cassette 1 cassette
Levodopa 20mg/ml / Carbidopa monohydrate 5mg/ml intestinal gel 100ml cassette 7 cassette

dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20241216000001, imported on 17th December 2024 at 04:01:15.

Feedback